Europska Unija - hrvatski - EMA (European Medicines Agency)

dopharma research b.v. - mcloksikam - oxicams - pigs; calves - cattlefor koristiti i kod akutne infekcije respiratornog odgovarajuće antibiotske terapije za smanjenje kliničkih znakova u goveda. za upotrebu u proljevu u kombinaciji s oralnom rehidracijskom terapijom kako bi se smanjili klinički znakovi u teladi starijoj od jednog tjedna i mlade, ne-laktirajuće stoke. za pomoćnu terapiju u liječenju akutnog mastitisa, u kombinaciji s antibiotskom terapijom. koristiti pigsfor u неинфекционной bolestima mišićno-koštanog sustava za ublažavanje simptoma hromost i upale. za olakšanje postoperativne boli povezane s manjim operacijama mekih tkiva kao što je kastracija. za pomoćnu terapiju u liječenju puerperalne septikemije i toksemije (mastitis-metritis-agalaktia sindrom) s odgovarajućom terapijom antibioticima. horsesfor koristiti za smanjenje upale i ublažavanje boli u akutni i kronični mišićno-koštanog sustava. za olakšanje boli povezane s kolikom kolica.

Europska Unija - hrvatski - EMA (European Medicines Agency)

mabxience research sl - bevacizumab - colorectal neoplasms; breast neoplasms; ovarian neoplasms; peritoneal neoplasms; carcinoma, non-small-cell lung; carcinoma, renal cell; uterine cervical neoplasms - antineoplastična sredstva - alymsys in combination with fluoropyrimidine based chemotherapy is indicated for treatment of adult patients with metastatic carcinoma of the colon or rectum. alymsys in combination with paclitaxel is indicated for first line treatment of adult patients with metastatic breast cancer. alymsys in combination with capecitabine is indicated for first line treatment of adult patients with metastatic breast cancer in whom treatment with other chemotherapy options including taxanes or anthracyclines is not considered appropriate. patients who have received taxane and anthracycline containing regimens in the adjuvant setting within the last 12 months should be excluded from treatment with alymsys in combination with capecitabine. alymsys, in addition to platinum based chemotherapy, is indicated for first line treatment of adult patients with unresectable advanced, metastatic or recurrent non small cell lung cancer other than predominantly squamous cell histology. alymsys, in combination with erlotinib, is indicated for first line treatment of adult patients with unresectable advanced, metastatic or recurrent non squamous non small cell lung cancer with epidermal growth factor receptor (egfr) activating mutations. alymsys in combination with interferon alfa 2a is indicated for first line treatment of adult patients with advanced and/or metastatic renal cell cancer. alymsys, in combination with carboplatin and paclitaxel is indicated for the front line treatment of adult patients with advanced (international federation of gynecology and obstetrics (figo) stages iii b, iii c and iv) epithelial ovarian, fallopian tube, or primary peritoneal cancer. alymsys, in combination with carboplatin and gemcitabine or in combination with carboplatin and paclitaxel, is indicated for treatment of adult patients with first recurrence of platinum sensitive epithelial ovarian, fallopian tube or primary peritoneal cancer who have not received prior therapy with bevacizumab or other vegf inhibitors or vegf receptor targeted agents. alymsys, in combination with topotecan, or pegylated liposomal doxorubicin is indicated for the treatment of adult patients with platinum resistant recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who received no more than two prior chemotherapy regimens and who have not received prior therapy with bevacizumab or other vegf inhibitors or vegf receptor targeted agents. alymsys, in combination with paclitaxel and cisplatin or, alternatively, paclitaxel and topotecan in patients who cannot receive platinum therapy, is indicated for the treatment of adult patients with persistent, recurrent, or metastatic carcinoma of the cervix.

Hrvatska - hrvatski - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

dopharma research b.v., zalmweg 24, 4941 vx raamsdonksveer, nizozemska - toltrazuril - oralna suspenzija - svinja (prasad u dobi 3 - 5 dana).

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

bontech research co. d.o.o., split - slušna pomagala

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

octapharma (ip) sprl, researchdreef 65, brussels (anderlecht), belgija - imunoglobulin normalni, ljudski - otopina za injekciju - 165 mg/ml - urbroj: jedan ml otopine sadrži: imunoglobulin normalni ljudski 165 mg (čistoće od najmanje 95% igg)

Hrvatska - hrvatski - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

dopharma research b.v., zalmweg 24, 4941 vx raamsdonksveer, nizozemska - deksametazon (u obliku natrijevog deksametazonfosfata) - otopina za injekciju - kortikosteroidi za sustavnu primjenu, deksametazon - goveda, konja, svinja, pasa, mačaka

Hrvatska - hrvatski - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

dopharma research b.v., zalmweg 24, 4941 vx raamsdonksveer, nizozemska - trimetoprim; sulfametoksazol - otopina za primjenu u vodi za piće - antibakterijski pripravci za sustavne infekcije - svinja (tovne svinje), kokoši (tovni pilići)

Hrvatska - hrvatski - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

dopharma research b.v., zalmweg 24, 4941 vx raamsdonksveer, nizozemska - tilozin - granule za primjenu u vodi za piće/mlijeku - antibakterijski vmp za sustavne infekcije - goveda (teladi), svinja, kokoši, purana

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

alkaloid d.o.o., slavonska avenija 6 a, zagreb, hrvatska - ciklosporin - kapsula, meka - 100 mg - urbroj: jedna meka kapsula sadrži 100 mg ciklosporina

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

alkaloid d.o.o., ulica grada vukovara 226f, zagreb - ciclosporinum - oralna otopina - 100 mg/ml - urbroj: 1 ml oralne otopine sadržava 100 mg ciklosporina